This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Huang, T.-S.
Right arrow Articles by Liu, Y.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huang, T.-S.
Right arrow Articles by Liu, Y.-C.

 Previous Article

Antimicrobial Agents and Chemotherapy, November 2003, p. 3672-3673, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3672-3673.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Correlation between Pyrazinamide Activity and pncA Mutations in Mycobacterium tuberculosis Isolates in Taiwan

Tsi-Shu Huang,1,2 Susan Shin-Jung Lee, Hui-Zin Tu,1 Wen-Kuei Huang,3 Yao-Shen Chen,3 Chung-Kai Huang,3 Shue-Ren Wann,3 Hsi-Hsun Lin,3 and Yung-Ching Liu1,3*

Section of Microbiology and Infectious Diseases, Kaohsiung Veterans General Hospital,1 Department of Medical Technology, Foo-Yin Institute of Technology,2 National Yang-Ming Medical College, Taipei, Taiwan3

Received 11 April 2003/ Returned for modification 6 July 2003/ Accepted 15 August 2003

A total of 76 clinical Mycobacterium tuberculosis isolates from Taiwan were tested for pyrazinamidase activity, pyrazinamide susceptibility, and pncA mutations. Frequency of resistance to PZA rose with increases in resistance to first-line drugs. Of 17 pyrazinamide-resistant strains, 7 (3 of which had not been previously described) possessed mutations in the pncA gene.


* Corresponding author. Mailing address: Kaohsiung Veterans General Hospital, Section of Infectious Diseases, 386 Ta-Chung 1st Rd., Kaohsiung, Taiwan, Republic of China. Phone: 886 7-346-8098. Fax: 866 7-346-8296. E-mail: ssjlee{at}vghks.gov.tw.


Antimicrobial Agents and Chemotherapy, November 2003, p. 3672-3673, Vol. 47, No. 11
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.11.3672-3673.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Singh, P., Wesley, C., Jadaun, G. P. S., Malonia, S. K., Das, R., Upadhyay, P., Faujdar, J., Sharma, P., Gupta, P., Mishra, A. K., Singh, K., Chauhan, D. S., Sharma, V. D., Gupta, U. D., Venkatesan, K., Katoch, V. M. (2007). Comparative Evaluation of Lowenstein-Jensen Proportion Method, BacT/ALERT 3D System, and Enzymatic Pyrazinamidase Assay for Pyrazinamide Susceptibility Testing of Mycobacterium tuberculosis. J. Clin. Microbiol. 45: 76-80 [Abstract] [Full Text]  
  • Barco, P., Cardoso, R. F., Hirata, R. D. C., Leite, C. Q. F., Pandolfi, J. R., Sato, D. N., Shikama, M. L., de Melo, F. F., Mamizuka, E. M., Campanerut, P. A. Z., Hirata, M. H. (2006). pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J Antimicrob Chemother 58: 930-935 [Abstract] [Full Text]  
  • McCammon, M. T., Gillette, J. S., Thomas, D. P., Ramaswamy, S. V., Rosas, I. I., Graviss, E. A., Vijg, J., Quitugua, T. N. (2005). Detection by Denaturing Gradient Gel Electrophoresis of pncA Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis Isolates from the United States-Mexico Border Region. Antimicrob. Agents Chemother. 49: 2210-2217 [Abstract] [Full Text]  
  • Rodrigues, V. d. F. S., Telles, M. A., Ribeiro, M. O., Cafrune, P. I., Rossetti, M. L. R., Zaha, A. (2005). Characterization of pncA Mutations in Pyrazinamide-Resistant Mycobacterium tuberculosis in Brazil. Antimicrob. Agents Chemother. 49: 444-446 [Abstract] [Full Text]